4//SEC Filing
Velleca Mark A. 4
Accession 0001415889-23-009959
CIK 0001701541other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:41 PM ET
Size
5.2 KB
Accession
0001415889-23-009959
Insider Transaction Report
Form 4
Velleca Mark A.
DirectorPRESIDENT & CEO
Transactions
- Award
Common Stock
2023-06-16$2.10/sh+8,929$18,751→ 41,314 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 15, 2023.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001706847
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:41 PM ET
- Size
- 5.2 KB